Literature DB >> 19904285

Measurement of density and affinity for dopamine D(2) receptors by a single positron emission tomography scan with multiple injections of [(11)C]raclopride.

Yoko Ikoma1, Hiroshi Watabe, Takuya Hayashi, Yoshinori Miyake, Noboru Teramoto, Kotaro Minato, Hidehiro Iida.   

Abstract

Positron emission tomography (PET) with [(11)C]raclopride has been used to investigate the density (B(max)) and affinity (K(d)) of dopamine D(2) receptors related to several neurological and psychiatric disorders. However, in assessing the B(max) and K(d), multiple PET scans are necessary under variable specific activities of administered [(11)C]raclopride, resulting in a long study period and unexpected physiological variations. In this paper, we have developed a method of multiple-injection graphical analysis (MI-GA) that provides the B(max) and K(d) values from a single PET scan with three sequential injections of [(11)C]raclopride, and we validated the proposed method by performing numerous simulations and PET studies on monkeys. In the simulations, the three-injection protocol was designed according to prior knowledge of the receptor kinetics, and the errors of B(max) and K(d) estimated by MI-GA were analyzed. Simulations showed that our method could support the calculation of B(max) and K(d), despite a slight overestimation compared with the true magnitudes. In monkey studies, we could calculate the B(max) and K(d) of diseased or normal striatum in a 150 mins scan with the three-injection protocol of [(11)C]raclopride. Estimated B(max) and K(d) values of D(2) receptors in normal or partially dopamine-depleted striatum were comparable to the previously reported values.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19904285      PMCID: PMC2949143          DOI: 10.1038/jcbfm.2009.239

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  32 in total

1.  Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol.

Authors:  Bradley T Christian; Tanjore Narayanan; Bing Shi; Evan D Morris; Joseph Mantil; Jogeshwar Mukherjee
Journal:  J Cereb Blood Flow Metab       Date:  2004-03       Impact factor: 6.200

2.  Parameter and index images of benzodiazepine receptor concentration in the brain.

Authors:  P Millet; J Delforge; F Mauguiere; S Pappata; L Cinotti; V Frouin; Y Samson; B Bendriem; A Syrota
Journal:  J Nucl Med       Date:  1995-08       Impact factor: 10.057

3.  Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: effect of methamphetamine.

Authors:  Doris J Doudet; James E Holden
Journal:  J Cereb Blood Flow Metab       Date:  2003-12       Impact factor: 6.200

4.  3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.

Authors:  A J Cross; T J Crow; F Owen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum.

Authors:  M Guttman; P Seeman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  K S Bankiewicz; E H Oldfield; C C Chiueh; J L Doppman; D M Jacobowitz; I J Kopin
Journal:  Life Sci       Date:  1986-07-07       Impact factor: 5.037

7.  Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.

Authors:  Yoshitsugu Oiwa; Jamie L Eberling; Dea Nagy; Phillip Pivirotto; Marina E Emborg; Krys S Bankiewicz
Journal:  Front Biosci       Date:  2003-09-01

Review 8.  Raclopride, a new selective ligand for the dopamine-D2 receptors.

Authors:  H Hall; C Köhler; L Gawell; L Farde; G Sedvall
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1988       Impact factor: 5.067

9.  Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.

Authors:  J Delforge; S Pappata; P Millet; Y Samson; B Bendriem; A Jobert; C Crouzel; A Syrota
Journal:  J Cereb Blood Flow Metab       Date:  1995-03       Impact factor: 6.200

10.  D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

Authors:  L Farde; F A Wiesel; S Stone-Elander; C Halldin; A L Nordström; H Hall; G Sedvall
Journal:  Arch Gen Psychiatry       Date:  1990-03
View more
  3 in total

Review 1.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90.

Authors:  Koen Vermeulen; Evelyne Naus; Muneer Ahamed; Bala Attili; Maxime Siemons; Kaat Luyten; Sofie Celen; Joost Schymkowitz; Frederic Rousseau; Guy Bormans
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

3.  Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C]Raclopride.

Authors:  Yoko Ikoma; Yasuyuki Kimura; Makiko Yamada; Takayuki Obata; Tetsuya Suhara; Hiroshi Ito
Journal:  Front Psychiatry       Date:  2022-07-12       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.